Vaccinex shareholders approve reverse stock split at ratio of 1:4 to 1:14

VACCINEX, INC.

Approved by 7,075,432 votes for, 258,830 against, 37,142 abstain.
Board authorized to implement reverse split at any ratio between 1-for-4 and 1-for-14.
Action likely intended to regain compliance with Nasdaq minimum bid price requirement.
Exact ratio and timing to be determined by Board at its discretion.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

VACCINEX, INC. shareholders approved Amendment to Certificate of Incorporation to effect a reverse stock split with a ratio between one-for-four and one-for-fourteen at the 2024-02-08 meeting.

Proposal: reverse split
Outcome: passed
Meeting: 2024-02-08

Exact text from the filing

Proposal 1. The Company’s stockholders approved and adopted an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of its issued common stock with one of several specified ratios between one-for-four and one-for-fourteen shares (the “Reverse Stock Split”), at the discretion of the Company’s Board of Directors (the “Board”). Votes For Votes Against Votes Abstained 7,075,432 258,830 37,142

View on SEC.gov

Browse all shareholder votes →

VACCINEX, INC. filing history →

Source: SEC EDGAR

accession 0001193125-24-033801

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.